PMID- 23400934 OWN - NLM STAT- MEDLINE DCOM- 20140303 LR - 20211203 IS - 1559-0283 (Electronic) IS - 1085-9195 (Linking) VI - 66 IP - 3 DP - 2013 Jul TI - Increased expression of the spindle checkpoint protein BubR1 is associated with high cell proliferation in primary gastrointestinal diffuse large B cell lymphoma. PG - 747-52 LID - 10.1007/s12013-013-9519-6 [doi] AB - Primary gastrointestinal diffuse large B cell lymphoma (PGI-DLBCL) is a relatively rare malignancy with limited results on clinical characteristics and carcinogenesis. Chromosome instability (CIN) is a hallmark of cancer cells, including lymphoma. As a key component of spindle assembly checkpoint (SAC), BubR1 plays a crucial role in maintaining genome stability. To elucidate the roles of BubR1 in the pathogenesis of PGI-DLBCL, and its relationship to cell proliferation, Helicobacter pylori infection, and BCL-6 gene translocation, we examined the possible alterations of BubR1 protein expression in PGI-DLBCL patients. Paraffin-embedded cancer tissues from 20 PGI-DLBCL patients were evaluated for BubR1 and H. pylori expression by immunohistochemistry, as well as cell proliferative activity measured by Ki-67 proliferation index (PI). BCL-6 gene rearrangement was assessed by fluorescence in situ hybridization (FISH) and BubR1 expression status was compared with clinicopathological parameters in PGI-DLBCL patients. Overexpression of BubR1 was observed in the majority of PGI-DLBCL patients. The mean expression level of BubR1 was 57.33 +/- 23.27% in PGI-DLBCL, which was higher than normal gastrointestinal tissue (10.18 +/- 5.65%) and reactive lymph node (26.74 +/- 8.60%) (P < 0.01), while it was comparable to nodal lymphoma (54.32 +/- 21.28%) (P > 0.05). BubR1 overexpression had a positive correlation with Ki-67 proliferation index (PI) (r = 0.51, P < 0.01) in PGI-DLBCL, but had no relationship to H. pylori infection and BCL-6 gene translocation. In addition, no correlation was found between BubR1 expression levels and overall survivals (P > 0.05). BubR1 overexpression was associated with cell proliferation and may play a role in the carcinogenesis of PGI-DLBCL. Aberrant BubR1 expression may potentially be a biomarker for estimating biologic characteristics of PGI-DLBCL. FAU - Chen, Fei AU - Chen F AD - Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan, People's Republic of China. FAU - Yang, Guifang AU - Yang G FAU - Xia, Bing AU - Xia B LA - eng PT - Journal Article PL - United States TA - Cell Biochem Biophys JT - Cell biochemistry and biophysics JID - 9701934 RN - 0 (BCL6 protein, human) RN - 0 (DNA-Binding Proteins) RN - 0 (Ki-67 Antigen) RN - 0 (Proto-Oncogene Proteins c-bcl-6) RN - EC 2.7.11.1 (BUB1 protein, human) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) SB - IM MH - Adult MH - Aged MH - Cell Proliferation MH - DNA-Binding Proteins/genetics MH - Female MH - Gastrointestinal Neoplasms/genetics/*metabolism/*pathology MH - *Gene Expression Regulation, Neoplastic MH - Gene Rearrangement MH - Humans MH - Ki-67 Antigen/metabolism MH - Lymphoma, Large B-Cell, Diffuse/genetics/*metabolism/*pathology MH - *M Phase Cell Cycle Checkpoints MH - Male MH - Middle Aged MH - Protein Serine-Threonine Kinases/*metabolism MH - Proto-Oncogene Proteins c-bcl-6 EDAT- 2013/02/13 06:00 MHDA- 2014/03/04 06:00 CRDT- 2013/02/13 06:00 PHST- 2013/02/13 06:00 [entrez] PHST- 2013/02/13 06:00 [pubmed] PHST- 2014/03/04 06:00 [medline] AID - 10.1007/s12013-013-9519-6 [doi] PST - ppublish SO - Cell Biochem Biophys. 2013 Jul;66(3):747-52. doi: 10.1007/s12013-013-9519-6.